These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16575008)

  • 1. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
    Richards WG; Zellos L; Bueno R; Jaklitsch MT; Jänne PA; Chirieac LR; Yeap BY; Dekkers RJ; Hartigan PM; Capalbo L; Sugarbaker DJ
    J Clin Oncol; 2006 Apr; 24(10):1561-7. PubMed ID: 16575008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
    Zellos L; Richards WG; Capalbo L; Jaklitsch MT; Chirieac LR; Johnson BE; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):453-8. PubMed ID: 19185169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
    Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
    Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative therapies: intraoperative intracavitary chemotherapy.
    Chang MY; Sugarbaker DJ
    Thorac Surg Clin; 2004 Nov; 14(4):549-56. PubMed ID: 15559062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura.
    Kasseyet S; Astoul P; Boutin C
    Cancer; 1999 Apr; 85(8):1740-9. PubMed ID: 10223568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural mesothelioma: surgical management in 285 patients.
    Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
    Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.
    Gupta V; Mychalczak B; Krug L; Flores R; Bains M; Rusch VW; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1045-52. PubMed ID: 16054774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
    Cao KJ; Cui NJ
    Ai Zheng; 2005 Jan; 24(1):72-5. PubMed ID: 15642204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
    Lee TT; Everett DL; Shu HK; Jahan TM; Roach M; Speight JL; Cameron RB; Phillips TL; Chan A; Jablons DM
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1183-9. PubMed ID: 12447185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
    Martin-Ucar AE; Nakas A; Edwards JG; Waller DA
    Eur J Cardiothorac Surg; 2007 May; 31(5):765-70; discussion 770-1. PubMed ID: 17337201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
    Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
    J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
    In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radical pleurectomy and hyperthermic intrathoracic chemotherapy for treatment of thymoma with pleural spread].
    Ried M; Neu R; Schalke B; Sziklavari Z; Hofmann HS
    Zentralbl Chir; 2013 Oct; 138 Suppl 1():S52-7. PubMed ID: 24150857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.
    Halstead JC; Lim E; Venkateswaran RM; Charman SC; Goddard M; Ritchie AJ
    Eur J Surg Oncol; 2005 Apr; 31(3):314-20. PubMed ID: 15780570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.